A collaborative health care model for the treatment of irritable bowel syndrome Charles D. Gerson, Mary-Joan Gerson Clinical Gastroenterology and Hepatology Volume 1, Issue 6, Pages 446-452 (November 2003) DOI: 10.1016/S1542-3565(03)00218-0
Figure 1 Progress of patients through the trial. Clinical Gastroenterology and Hepatology 2003 1, 446-452DOI: (10.1016/S1542-3565(03)00218-0)
Figure 2 Global improvement in IBS symptoms. Percentage median improvement by visual analog scale in group 1 (collaborative), group 2 (gastrointestinal [GI]), and group 3 (psychological). ∗P < 0.0002. Clinical Gastroenterology and Hepatology 2003 1, 446-452DOI: (10.1016/S1542-3565(03)00218-0)
Figure 3 Quantitative analysis of improvement in IBS symptoms for all treatment groups over time. Symptom scores from t-1 were compared with those from t-2 and t-3. In group 1, there was significant improvement in the 3 main symptoms of abdominal pain, diarrhea, and constipation from t-1 to t-3, evaluated as a composite score (P < 0.001). GI, gastrointestinal. Clinical Gastroenterology and Hepatology 2003 1, 446-452DOI: (10.1016/S1542-3565(03)00218-0)